Celera Celera develops and commercializes diagnostic tests that identify disease risk and help physicians and patients manage disease development. Our Products business develops and manufactures molecular diagnostic products that are used to detect, characterize, monitor and select treatment for disease, while our Services business, Berkeley HeartLab, Inc. (BHL), offers many diagnostic tests to identify and characterize risk for cardiovascular disease and help physicians recommend treatment.